menu
    • menu

    Company profile for Invenra

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Invenra, Inc., is a biotechnology company focused on the discovery and development of multispecific antibodies for immuno-oncology. Invenra’s proprietary B-Body™ and SNIPER™ technologies are used to develop novel antibodies that can bind to two or more specific therapeutic targets and mimic the natural IgG antibodies made by the human body. The B-Body™ platform enables the rapid identification of an optimal combinatio...
    Invenra, Inc., is a biotechnology company focused on the discovery and development of multispecific antibodies for immuno-oncology. Invenra’s proprietary B-Body™ and SNIPER™ technologies are used to develop novel antibodies that can bind to two or more specific therapeutic targets and mimic the natural IgG antibodies made by the human body. The B-Body™ platform enables the rapid identification of an optimal combination of epitope, affinity and geometry [of an antibody] using high throughput in-format screening for function in cell-based assays, while maintaining the biophysical characteristics needed for lead development.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    InvenraUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    505 South Rosa Road Suite 235 Madison, WI 53719
    Telephone
    Telephone
    608.441.8319
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://invenra.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/invenra
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/invenra

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Invenra, Xcellon Partner to Advance Bispecific ADC Development
    Invenra, Xcellon Partner to Advance Bispecific ADC Development

    22 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251022148688/en/Invenra-Inc.-and-Xcellon-Biologics-Announce-Collaboration-to-Advance-Bispecific-and-Trispecific-Antibody-Drug-Conjugate-ADC-Development

    BUSINESSWIRE
    22 Oct 2025
    Share Share
    Invenra Welcomes Dr. Alan J. Korman to Advisory Board
    Invenra Welcomes Dr. Alan J. Korman to Advisory Board

    14 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250714417099/en/Invenra-Welcomes-Dr.-Alan-J.-Korman-to-Its-Scientific-Advisory-Board

    BUSINESSWIRE
    14 Jul 2025
    Share Share
    Invenra Highlights Exelixis Phase 1 Study of XB628 in Solid Tumor
    Invenra Highlights Exelixis Phase 1 Study of XB628 in Solid Tumor

    13 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250513934175/en/Invenra-Highlights-Exelixis-Initiation-of-Phase-1-Clinical-Study-Evaluating-XB628-a-First-in-Class-Bispecific-Antibody-in-Participants-with-Recurrent-Advanced-or-Metastatic-Solid-Tumors

    BUSINESSWIRE
    13 May 2025
    Share Share
    Invenra Launches T-Body™ Trispecific Platform for Antibodies
    Invenra Launches T-Body™ Trispecific Platform for Antibodies

    13 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250513446303/en/Invenra-Launches-T-Body-Trispecific-Platform-to-Advance-Next-Generation-Therapeutic-Antibodies

    BUSINESSWIRE
    13 May 2025
    Share Share
    Invenra Launches B-Body Express Bispecific Platform
    Invenra Launches B-Body Express Bispecific Platform

    22 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250422436080/en/Invenra-Launches-B-Body-Express-Service-Enabling-Rapid-Access-to-its-Premier-B-Body-Bispecific-Antibody-Platform

    BUSINESSWIRE
    22 Apr 2025
    Share Share
    Invenra, Orion Partner For Bispecific Antibody Cancer Therapy
    Invenra, Orion Partner For Bispecific Antibody Cancer Therapy

    30 Jan 2025

    // PRESS RELEASE

    https://production.orion.fi/newsroom/all-news/releases/press-releases/2025/orion-and-invenra-announce-discovery-service-and-commercial-license-agreement-to-develop-innovative-bispecific-antibody-cancer-therapeutics/

    PRESS RELEASE
    30 Jan 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search